US Patent 11186644 Anti-neuropilin antigen-binding proteins and methods of use thereof
Patent 11186644 was granted and assigned to Potenza Therapeutics on November, 2021 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
January 3, 2019
Date of Patent
November 30, 2021
Patent Applicant
Patent Application Number
16239234
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11186644 Anti-neuropilin antigen-binding proteins and methods of use thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
